ponatinib
SpainDrugs containing this active substance
-
It is used to treat adults with chronic myeloid leukemia (CML) or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) who no longer respond to other treatments or who have a specific genetic mutation called T315I.
Form: tablets, film-coated
Active substance Dosage ponatinib 15 mg Manufacturer: Incyte Biosciences Distribution B.V.
-
It is used to treat adults with chronic myeloid leukemia (CML) or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) who no longer respond to other treatments or who have a specific genetic mutation called T315I.
Form: tablets, film-coated
Active substance Dosage ponatinib 30 mg Manufacturer: Incyte Biosciences Distribution B.V.
-
It is used to treat adults with chronic myeloid leukemia (CML) or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) who no longer respond to other treatments or who have a specific genetic mutation called T315I.
Form: tablets
Active substance Dosage ponatinib 45 mg Manufacturer: Incyte Biosciences Distribution B.V.